How to buy Kronos Bio stock

Kronos Bio, Inc is an other business based in the US. Kronos Bio shares (KRON) are listed on the NASDAQ and all prices are listed in US Dollars. Kronos Bio employs 61 staff and has a market cap (total outstanding shares value) of USD$1.7 billion.

How to buy shares in Kronos Bio

1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
3. Search for Kronos Bio. Find the stock by name or ticker symbol: KRON. Research its history to confirm it's a solid investment against your financial goals.
4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Kronos Bio reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Kronos Bio, depending on your broker.
6. Check in on your investment. Congratulations, you own a part of Kronos Bio. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Our top pick for

Beginners

Robinhood

Our top pick for

Building a portfolio

Sofi Invest

Our top pick for

Advanced investors

Webull

How we chose our top picks

We evaluate stock trading platforms against a range of metrics that include fees, ease of use, available securities and advanced tools to meet specific investor needs. We encourage you to compare stock platforms to find one that's best for your particular budget and goals.

• Our pick for beginners. We chose Robinhood for this category because it offers commission-free trading and is easy to use. You can search for stocks by company name, and the mobile app is clean and intuitive to use.
• Our pick for building a portfolio. We chose SoFi for this category because it offers both commission-free stocks and a free robo-advisor. That means you can open an active investing account to pick and choose companies you want to invest in, and open a robo-advisor account to help you build a portfolio and manage how much risk you take on.
• Our pick for active investors. We picked Webull for this category because its platform offers features that cater to advancing investors as well as beginners. The desktop app is outfitted with an extensive set of research tools, the mobile app gets high grades from users and traders can test strategies with a paper-trading feature.

What's in this guide?

1. KRON shares summary
2. Compare share dealing platforms
3. Is KRON stock a buy or sell?
4. Stock performance over time
5. Can I short KRON shares?
6. Kronos Bio's financials
7. Does Kronos Bio pay a dividend?
8. Other common questions

Kronos Bio share price

Use our graph to track the performance of KRON stocks over time.

Kronos Bio shares at a glance

• Key figures

Information last updated 2021-03-03.

52-week range	USD$25.5006 - USD$39.605
50-day moving average	USD$29.4762
200-day moving average	USD$30.665
Wall St. target price	USD$43.67
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	N/A

Buy Kronos Bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

Sort by:

Name	Product	Stock trade fee	Asset types	Option trade fee	Annual fee	Signup bonus
Robinhood		$0	Stocks, Options, ETFs, Gold/Commodities	$0	0%	Free stock (chosen randomly with a value anywhere between $2.50 and $200) Sign up using the "go to site" link	Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.	Go to site More Info		loading Fetching your data...
Webull		$0	Stocks, Options, ETFs	$0	0%	Get two free stock valued between $2.50 and $250 Open an account	Margin financing rates start at 3.99%. No monthly subscription fees for margin.	Go to site More Info		loading Fetching your data...
TradeStation		$0	Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency	$0 + $0.50/contract		$50 Deposit qualifying assets of $5,000+	A platform built for all kinds of traders and all styles of trading	Go to site More Info		loading Fetching your data...
Tastyworks		$0	Stocks, Options, Cryptocurrency	Stocks & ETFs: $1/contract to open, $0 to close, $10 max/leg Futures: $2.50/contract to open, $0 to close	0%	Get 100 shares of stock (worth $1 to $6 a share) Open and fund a new cash or margin account with $2,000+	Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.	Go to site More Info		loading Fetching your data...
Interactive Brokers		$0	Stocks, Bonds, Options	$0 + $0.65/contract, $1 minimum	0%	N/A	IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.	Go to site More Info		loading Fetching your data...

loading

Compare up to 4 providers

Clear selection

Compare

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kronos Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Kronos Bio, Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Shorting Kronos Bio shares

There are currently 2.2 million Kronos Bio shares held short by investors – that's known as Kronos Bio's "short interest". This figure is 8.3% up from 2.0 million last month.

There are a few different ways that this level of interest in shorting Kronos Bio shares can be evaluated.

Kronos Bio's "short interest ratio" (SIR)

Kronos Bio's "short interest ratio" (SIR) is the quantity of Kronos Bio shares currently shorted divided by the average quantity of Kronos Bio shares traded daily (recently around 110264.92462312). Kronos Bio's SIR currently stands at 19.9. In other words for every 100,000 Kronos Bio shares traded daily on the market, roughly 19900 shares are currently held short.

To gain some more context, you can compare Kronos Bio's short interest ratio against those of similar companies.

• Exact Sciences Corporation (EXAS.US): 5.1
• Inovio Pharmaceuticals (INO.US): 1.91
• Moderna (MRNA.US): 0.99

However Kronos Bio's short interest can also be evaluated against the total number of Kronos Bio shares, or, against the total number of tradable Kronos Bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Kronos Bio's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Kronos Bio shares in existence, roughly 40 shares are currently held short) or 0.0566% of the tradable shares (for every 100,000 tradable Kronos Bio shares, roughly 57 shares are currently held short).

A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Kronos Bio.

Find out more about how you can short Kronos Bio stock.

Kronos Bio overview

Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib, a selective inhibitor targeting spleen tyrosine kinase in acute myeloid leukemia patients. The company is also developing KB-0742, an orally bioavailable inhibitor of cyclin dependent kinase 9 for the treatment of MYC-amplified solid tumors. Kronos Bio, Inc. is founded in 2017 and is headquartered in San Mateo, California.

Frequently asked questions

• What percentage of Kronos Bio is owned by insiders or institutions?

  Currently 13.308% of Kronos Bio shares are held by insiders and 13.815% by institutions.

• How many people work for Kronos Bio?

  Latest data suggests 61 work at Kronos Bio.

• When does the fiscal year end for Kronos Bio?

  Kronos Bio's fiscal year ends in December.

• Where is Kronos Bio based?

  Kronos Bio's address is: 1300 South El Camino Real, San Mateo, CA, United States, 94402

• What is Kronos Bio's ISIN number?

  Kronos Bio's international securities identification number is: US50107A1043

• What is Kronos Bio's CUSIP number?

  Kronos Bio's Committee on Uniform Securities Identification Procedures number is: 501052104